Trial intelligence / Profile preview

Anakinra versus usual care for acute gout flares

NL-OMON47178Active, not recruiting

Sponsor
University of Twente
Start
Feb 2016
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, double-blind trial in gout comparing Anakinra arm with Standard-of-care arm (2 arms). Primary endpoint: Change in patient-reported pain in the index joint from baseline to the average of pain values at 24, 48 and 72 hours. Started Feb 2016; status: active, not recruiting.

02

Drugs

anakinra
03

Conditions

gout

Beyond the preview

Go deeper on NL-OMON47178.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON47178.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call